508 related articles for article (PubMed ID: 29922917)
1. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.
Torre S; Langlais D; Gros P
Mamm Genome; 2018 Aug; 29(7-8):488-506. PubMed ID: 29922917
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
4. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.
Amani V; Boubou MI; Pied S; Marussig M; Walliker D; Mazier D; Rénia L
Infect Immun; 1998 Sep; 66(9):4093-9. PubMed ID: 9712753
[TBL] [Abstract][Full Text] [Related]
5. Early cytokine production is associated with protection from murine cerebral malaria.
Mitchell AJ; Hansen AM; Hee L; Ball HJ; Potter SM; Walker JC; Hunt NH
Infect Immun; 2005 Sep; 73(9):5645-53. PubMed ID: 16113282
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Malaria Is Regulated by Host-Mediated Changes in
Cimperman CK; Pena M; Gokcek SM; Theall BP; Patel MV; Sharma A; Qi C; Sturdevant D; Miller LH; Collins PL; Pierce SK; Akkaya M
mBio; 2023 Apr; 14(2):e0339122. PubMed ID: 36852995
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
8. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
9. A
Fernandes P; Howland SW; Heiss K; Hoffmann A; Hernández-Castañeda MA; Obrová K; Frank R; Wiedemann P; Bendzus M; Rénia L; Mueller AK
Front Immunol; 2018; 9():1875. PubMed ID: 30154793
[TBL] [Abstract][Full Text] [Related]
10. The Glycosylphosphatidylinositol Transamidase Complex Subunit PbGPI16 of Plasmodium berghei Is Important for Inducing Experimental Cerebral Malaria.
Liu Q; Zhao Y; Zheng L; Zhu X; Cui L; Cao Y
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29784863
[TBL] [Abstract][Full Text] [Related]
11. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
[TBL] [Abstract][Full Text] [Related]
12. Detection of a new cerebral malaria susceptibility locus, using CBA mice.
Ohno T; Nishimura M
Immunogenetics; 2004 Dec; 56(9):675-8. PubMed ID: 15536567
[TBL] [Abstract][Full Text] [Related]
13. Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice.
Akkaya M; Bansal A; Sheehan PW; Pena M; Cimperman CK; Qi CF; Yazew T; Otto TD; Billker O; Miller LH; Pierce SK
Sci Rep; 2020 Aug; 10(1):13630. PubMed ID: 32788672
[TBL] [Abstract][Full Text] [Related]
14. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
Canavese M; Dottorini T; Crisanti A
Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
[TBL] [Abstract][Full Text] [Related]
15. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
16. Using a new three-dimensional CUBIC tissue-clearing method to examine the brain during experimental cerebral malaria.
Matsuo-Dapaah J; Lee MSJ; Ishii KJ; Tainaka K; Coban C
Int Immunol; 2021 Oct; 33(11):587-594. PubMed ID: 34455438
[TBL] [Abstract][Full Text] [Related]
17. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
Keita Alassane S; Nicolau-Travers ML; Menard S; Andreoletti O; Cambus JP; Gaudre N; Wlodarczyk M; Blanchard N; Berry A; Abbes S; Colongo D; Faye B; Augereau JM; Lacroux C; Iriart X; Benoit-Vical F
PLoS One; 2017; 12(7):e0181300. PubMed ID: 28742109
[TBL] [Abstract][Full Text] [Related]
18. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
19. Experimental cerebral malaria is suppressed by disruption of nucleoside transporter 1 but not purine nucleoside phosphorylase.
Niikura M; Inoue S; Mineo S; Yamada Y; Kaneko I; Iwanaga S; Yuda M; Kobayashi F
Biochem Biophys Res Commun; 2013 Mar; 432(3):504-8. PubMed ID: 23402751
[TBL] [Abstract][Full Text] [Related]
20. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
